Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer.
Vivek Mishra, Manjari Mishra, Kausar M Ansari, Bhushan P Chaudhari, Raj Khanna, Mukul Das
文献索引:Eur. J. Cancer 48(13) , 2075-85, (2012)
全文:HTML全文
摘要
Carcinogenic potential of argemone oil (AO) and butter yellow (BY), the adulterants encountered in edible oil, in gall bladder of Swiss albino mice was undertaken to investigate the potential aetiological factors of gall bladder carcinoma (GBC) in the Indo-Gangetic basin. Twice weekly intraperitoneal (ip) administration of AO (5 ml/kg body wt) and BY (25 mg/kg body wt) to Swiss albino male and female mice for 30 and 60 days indicated that females were more vulnerable to these adulterants in terms of responses to inflammatory markers. Subsequent experiments with dietary exposure of AO (1%) and BY (0.06%) for 6 months in female mice showed symptoms related to cachexia, jaundice and anaemia. High levels of total cholesterol, low density lipoprotein (LDL), TG, bilirubin and low level of high density lipoprotein (HDL) as well as gallstone formation was shown by AO exposure only, leading to the development of adenocarcinoma. BY exposure resulted in adenoma and hyperplasia without stone formation. The cyclooxygenase (COX-2) overexpression was found to be related to prostaglandin E2 (PGE2) production in AO treated mice but not in BY exposed animals, thereby indicating a differential pathway specific carcinogenicity. PGE2 stimulates the secretion of secreted mucins (MUC5AC), which is involved in stone formation following AO exposure. Enhanced secretion of membrane bound mucins (MUC4) in BY and AO exposed mice resulted in the activation of ErbB2 and downstream signalling such as p-AKT, p-ERK and p-JNK, which ultimately affects the target proteins, p53 and p21 leading to adenoma and adenocarcinoma, respectively. The study suggests that AO and BY are responsible for producing GBC in mice along with stone formation in the AO exposed animals.Copyright © 2011 Elsevier Ltd. All rights reserved.
相关化合物
相关文献:
2015-01-01
[PLoS ONE 10(3) , e0118824, (2015)]
2011-06-07
[Biochemistry 50(22) , 4830-42, (2011)]
2013-02-01
[Electrophoresis 34(3) , 401-4, (2013)]
2012-09-01
[J. Mol. Model. 18(9) , 4113-20, (2012)]
2010-12-01
[Bioorg. Med. Chem. Lett. 20(23) , 6905-8, (2010)]